Truncus arteriosus repair: Outcomes, risk factors, reoperation and management

John W. Brown, Mark Ruzmetov, Yuji Okada, Palaniswamy Vijay, Mark W. Turrentine

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Objectives: Truncus arteriosus (TA) continues to be associated with significant morbidity and mortality, but there have been clinically significant improvements with early repair. Methods: Sixty patients underwent physiological correction of TA between November 1978 and January 2000. The average age was 76 days (range, 3 days-20 months). Associated cardiac anomalies were frequently encountered, the most common being severe truncal valve regurgitation (n = 7), interrupted aortic arch (n = 6), coronary artery anomalies (n = 6), non-confluent pulmonary arteries (n = 4), and total anomalous pulmonary venous return (n = 1). Truncal valve replacement was performed initially or subsequently in seven patients with severe regurgitation (mechanical prostheses in six patients and a cryopreserved aortic homograft in one patient). Right ventricle-pulmonary artery continuity was established with an aortic (n = 16) or pulmonary homograft (n = 32) in 48 patients, a Dacron polyester porcine valved conduit in five, a non-valved polytetrafluoroethylene (PTFE) tube in three, direct anastomosis to the right ventricle with anterior patch arterioplasty in three, and a bovine jugular venous valve conduit in one patient. Results: There were ten hospital deaths (17%; 70% confidence limit, 7-25%). Multivariate and univariate analyses demonstrated a relationship between hospital mortality and associated cardiac anomalies. In the 43 patients without these associated cardiac anomalies, the early survival was 91% (group I). In the 17 patients with one or more of these risk factors, the survival was 71% (group II, P = 0.002). There was one late death. Twenty-three patients (46%) required reoperation for right ventricular outflow tract (RVOT) obstruction at a mean follow-up time of 59.1 months. In 23 patients, the RVOT reconstruction was performed with a PTFE monocusp, and six patients had of a variety of replacement conduits inserted. Postoperatively, there were 34 (68%) patients in New York Heart Association functional class I and 16 (32%) in class II. Twenty-eight surviving patients are reported as doing well without any medication. The freedom of reoperation in the 39 hospital survivors (group I) without risk factors was 64% at 7 years; and 36% at 10 years in the 11 patients (group II) surviving with risk factors. Conclusions: Associated cardiac anomalies were risk factors for death after the repair of TA. In the absence of these associated lesions, TA can be repaired with an excellent surgical outcome in the neonatal and early infancy period.

Original languageEnglish (US)
Pages (from-to)221-227
Number of pages7
JournalEuropean Journal of Cardio-thoracic Surgery
Volume20
Issue number2
DOIs
StatePublished - Jan 1 2001

Fingerprint

Truncus Arteriosus
Risk Management
Reoperation
Polytetrafluoroethylene
Pulmonary Artery
Heart Ventricles
Allografts
Venous Valves
Scimitar Syndrome
Ventricular Outflow Obstruction
Polyethylene Terephthalates
Polyesters
Survival
Patient Rights
Hospital Mortality
Thoracic Aorta

Keywords

  • Children
  • Congenital valve disease
  • Truncal valve
  • Truncus arteriosus communis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Truncus arteriosus repair : Outcomes, risk factors, reoperation and management. / Brown, John W.; Ruzmetov, Mark; Okada, Yuji; Vijay, Palaniswamy; Turrentine, Mark W.

In: European Journal of Cardio-thoracic Surgery, Vol. 20, No. 2, 01.01.2001, p. 221-227.

Research output: Contribution to journalArticle

@article{1aaee16aa2de40afac00db49cfc9b98e,
title = "Truncus arteriosus repair: Outcomes, risk factors, reoperation and management",
abstract = "Objectives: Truncus arteriosus (TA) continues to be associated with significant morbidity and mortality, but there have been clinically significant improvements with early repair. Methods: Sixty patients underwent physiological correction of TA between November 1978 and January 2000. The average age was 76 days (range, 3 days-20 months). Associated cardiac anomalies were frequently encountered, the most common being severe truncal valve regurgitation (n = 7), interrupted aortic arch (n = 6), coronary artery anomalies (n = 6), non-confluent pulmonary arteries (n = 4), and total anomalous pulmonary venous return (n = 1). Truncal valve replacement was performed initially or subsequently in seven patients with severe regurgitation (mechanical prostheses in six patients and a cryopreserved aortic homograft in one patient). Right ventricle-pulmonary artery continuity was established with an aortic (n = 16) or pulmonary homograft (n = 32) in 48 patients, a Dacron polyester porcine valved conduit in five, a non-valved polytetrafluoroethylene (PTFE) tube in three, direct anastomosis to the right ventricle with anterior patch arterioplasty in three, and a bovine jugular venous valve conduit in one patient. Results: There were ten hospital deaths (17{\%}; 70{\%} confidence limit, 7-25{\%}). Multivariate and univariate analyses demonstrated a relationship between hospital mortality and associated cardiac anomalies. In the 43 patients without these associated cardiac anomalies, the early survival was 91{\%} (group I). In the 17 patients with one or more of these risk factors, the survival was 71{\%} (group II, P = 0.002). There was one late death. Twenty-three patients (46{\%}) required reoperation for right ventricular outflow tract (RVOT) obstruction at a mean follow-up time of 59.1 months. In 23 patients, the RVOT reconstruction was performed with a PTFE monocusp, and six patients had of a variety of replacement conduits inserted. Postoperatively, there were 34 (68{\%}) patients in New York Heart Association functional class I and 16 (32{\%}) in class II. Twenty-eight surviving patients are reported as doing well without any medication. The freedom of reoperation in the 39 hospital survivors (group I) without risk factors was 64{\%} at 7 years; and 36{\%} at 10 years in the 11 patients (group II) surviving with risk factors. Conclusions: Associated cardiac anomalies were risk factors for death after the repair of TA. In the absence of these associated lesions, TA can be repaired with an excellent surgical outcome in the neonatal and early infancy period.",
keywords = "Children, Congenital valve disease, Truncal valve, Truncus arteriosus communis",
author = "Brown, {John W.} and Mark Ruzmetov and Yuji Okada and Palaniswamy Vijay and Turrentine, {Mark W.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S1010-7940(01)00816-8",
language = "English (US)",
volume = "20",
pages = "221--227",
journal = "European Journal of Cardio-thoracic Surgery",
issn = "1010-7940",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Truncus arteriosus repair

T2 - Outcomes, risk factors, reoperation and management

AU - Brown, John W.

AU - Ruzmetov, Mark

AU - Okada, Yuji

AU - Vijay, Palaniswamy

AU - Turrentine, Mark W.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Objectives: Truncus arteriosus (TA) continues to be associated with significant morbidity and mortality, but there have been clinically significant improvements with early repair. Methods: Sixty patients underwent physiological correction of TA between November 1978 and January 2000. The average age was 76 days (range, 3 days-20 months). Associated cardiac anomalies were frequently encountered, the most common being severe truncal valve regurgitation (n = 7), interrupted aortic arch (n = 6), coronary artery anomalies (n = 6), non-confluent pulmonary arteries (n = 4), and total anomalous pulmonary venous return (n = 1). Truncal valve replacement was performed initially or subsequently in seven patients with severe regurgitation (mechanical prostheses in six patients and a cryopreserved aortic homograft in one patient). Right ventricle-pulmonary artery continuity was established with an aortic (n = 16) or pulmonary homograft (n = 32) in 48 patients, a Dacron polyester porcine valved conduit in five, a non-valved polytetrafluoroethylene (PTFE) tube in three, direct anastomosis to the right ventricle with anterior patch arterioplasty in three, and a bovine jugular venous valve conduit in one patient. Results: There were ten hospital deaths (17%; 70% confidence limit, 7-25%). Multivariate and univariate analyses demonstrated a relationship between hospital mortality and associated cardiac anomalies. In the 43 patients without these associated cardiac anomalies, the early survival was 91% (group I). In the 17 patients with one or more of these risk factors, the survival was 71% (group II, P = 0.002). There was one late death. Twenty-three patients (46%) required reoperation for right ventricular outflow tract (RVOT) obstruction at a mean follow-up time of 59.1 months. In 23 patients, the RVOT reconstruction was performed with a PTFE monocusp, and six patients had of a variety of replacement conduits inserted. Postoperatively, there were 34 (68%) patients in New York Heart Association functional class I and 16 (32%) in class II. Twenty-eight surviving patients are reported as doing well without any medication. The freedom of reoperation in the 39 hospital survivors (group I) without risk factors was 64% at 7 years; and 36% at 10 years in the 11 patients (group II) surviving with risk factors. Conclusions: Associated cardiac anomalies were risk factors for death after the repair of TA. In the absence of these associated lesions, TA can be repaired with an excellent surgical outcome in the neonatal and early infancy period.

AB - Objectives: Truncus arteriosus (TA) continues to be associated with significant morbidity and mortality, but there have been clinically significant improvements with early repair. Methods: Sixty patients underwent physiological correction of TA between November 1978 and January 2000. The average age was 76 days (range, 3 days-20 months). Associated cardiac anomalies were frequently encountered, the most common being severe truncal valve regurgitation (n = 7), interrupted aortic arch (n = 6), coronary artery anomalies (n = 6), non-confluent pulmonary arteries (n = 4), and total anomalous pulmonary venous return (n = 1). Truncal valve replacement was performed initially or subsequently in seven patients with severe regurgitation (mechanical prostheses in six patients and a cryopreserved aortic homograft in one patient). Right ventricle-pulmonary artery continuity was established with an aortic (n = 16) or pulmonary homograft (n = 32) in 48 patients, a Dacron polyester porcine valved conduit in five, a non-valved polytetrafluoroethylene (PTFE) tube in three, direct anastomosis to the right ventricle with anterior patch arterioplasty in three, and a bovine jugular venous valve conduit in one patient. Results: There were ten hospital deaths (17%; 70% confidence limit, 7-25%). Multivariate and univariate analyses demonstrated a relationship between hospital mortality and associated cardiac anomalies. In the 43 patients without these associated cardiac anomalies, the early survival was 91% (group I). In the 17 patients with one or more of these risk factors, the survival was 71% (group II, P = 0.002). There was one late death. Twenty-three patients (46%) required reoperation for right ventricular outflow tract (RVOT) obstruction at a mean follow-up time of 59.1 months. In 23 patients, the RVOT reconstruction was performed with a PTFE monocusp, and six patients had of a variety of replacement conduits inserted. Postoperatively, there were 34 (68%) patients in New York Heart Association functional class I and 16 (32%) in class II. Twenty-eight surviving patients are reported as doing well without any medication. The freedom of reoperation in the 39 hospital survivors (group I) without risk factors was 64% at 7 years; and 36% at 10 years in the 11 patients (group II) surviving with risk factors. Conclusions: Associated cardiac anomalies were risk factors for death after the repair of TA. In the absence of these associated lesions, TA can be repaired with an excellent surgical outcome in the neonatal and early infancy period.

KW - Children

KW - Congenital valve disease

KW - Truncal valve

KW - Truncus arteriosus communis

UR - http://www.scopus.com/inward/record.url?scp=0034896055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034896055&partnerID=8YFLogxK

U2 - 10.1016/S1010-7940(01)00816-8

DO - 10.1016/S1010-7940(01)00816-8

M3 - Article

C2 - 11463535

AN - SCOPUS:0034896055

VL - 20

SP - 221

EP - 227

JO - European Journal of Cardio-thoracic Surgery

JF - European Journal of Cardio-thoracic Surgery

SN - 1010-7940

IS - 2

ER -